無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

心血管超音波システムの世界市場:市場考察、機会分析、市場シェア、予測

Global Cardiovascular Ultrasound Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

発行 Occams Business Research & Consulting Pvt. Ltd. 商品コード 577327
出版日 ページ情報 英文 190 Pages
納期: お問合せ
価格
本日の銀行送金レート: 1USD=114.54円で換算しております。
Back to Top
心血管超音波システムの世界市場:市場考察、機会分析、市場シェア、予測 Global Cardiovascular Ultrasound Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023
出版日: 2017年10月30日 ページ情報: 英文 190 Pages
概要

当レポートでは、心血管超音波システムの世界市場について調査し、市場の概要、検査タイプ・技術・ディスプレイタイプ・エンドユーザー・地域別の市場動向、市場規模の推移と予測(過去3年間・今後7年間分)、市場促進・阻害要因および市場機会・課題の分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

第1章 イントロダクション

  • エグゼクティブサマリー
  • 推計手法

第2章 市場概要

  • 心血管超音波システム世界市場:発展と変遷
  • 市場の定義と範囲
  • 産業構造
  • 市場分析
  • 予測分析
  • 戦略分析
    • 投資 vs 導入モデル
    • 全方位的産業分析
    • ファイブフォース分析
    • シーソー分析
    • コンシューマー分析・主な購買基準
  • 競合分析
    • 主要戦略の分析
    • 市場シェアおよび上位企業の分析
  • 戦略提言と総論
    • 地域別の投資機会
    • 新用途における市場機会
    • 最速成長市場の投資機会

第3章 市場の決定要因

  • 促進要因
  • 阻害要因
  • 市場機会
  • 課題

第4章 心血管超音波システムの世界市場:セグメント別

  • 心血管超音波システムの世界市場:タイプ別
    • 経胸壁エコー検査
    • 経食道エコー検査
    • ストレスエコー検査
    • その他のエコー検査
  • 心血管超音波システムの世界市場:技術別
    • 2D
    • 3D & 4D
    • ドプラ法
  • 心血管超音波システムの世界市場:ディスプレイタイプ別
    • カラーディスプレイ
    • モノクロディスプレイ
  • 心血管超音波システムの世界市場:エンドユーザー別
    • 病院 & 心疾患センター
    • 外来外科センター & 在宅ケア
    • その他

第5章 競合情勢

  • 主な戦略
    • 合併・買収
    • 合弁事業
    • 製品の上市
    • パートナーシップ
  • 上位10社の分析

第6章 心血管超音波システムの世界市場:地域別

  • 意思決定支援データベース・推計手法
  • 市場セグメントの比較分析
  • 市場機会のマトリクス
  • 地域区分
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第7章 企業プロファイル

  • GE HEALTHCARE
  • PHILIPS HEALTHCARE
  • SIEMENS HEALTHCARE
  • 日立メディコ
  • 東芝メディカルシステムズ
  • MINDRAY MEDICAL INTERNATIONAL LIMITED
  • SAMSUNG ELECTRONICS CO., LTD.
  • 富士フィルム
  • ESAOTE S.P.A.
  • CHISON MEDICAL IMAGING CO., LTD.
  • ULTRASOUND TECHNOLOGIES LTD.
  • UNETIXS VASCULAR, INC.
  • KALAMED MEDICAL SYSTEMS
  • TRIVITRON HEALTHCARE
  • SUPERSONIC IMAGINE
目次
Product Code: HME-8111017

An ultrasound system creates images known as sonograms. The global cardiovascular ultrasound system market is expected to rise at a CAGR of 6% during the forecast period 2016-2023. The key factor contributing to the market are technological advancement, increasing prevalence of cardiovascular diseases, advantage of echocardiography over invasive cardiac diagnostic procedures as well as increasing healthcare expenditure. According to Institute Of Health Metrics And Evaluation, global spending on health is expected to reach to $ 18.28 trillion worldwide by 2040. However, economic influence of adopting new technologies and insufficient reimbursement scenario are restraining the growth of cardiovascular ultrasound system market.

Global cardiovascular ultrasound system market report covers segmentation analysis of test type, technology, device display and end user. Report further covers segments of test type which includes transthoracic echocardiogram, transesophageal echocardiogram, stress echocardiogram and other echocardiograms. The stress echocardiogram is the leading test type segment in 2016. This is owing to the major advantages such as ready availability, incremental value, low capital cost that allows characterization of cardiac anatomy and myocardial response to a potentially ischemic stimulus. Moreover, stress echocardiogram provide data of cardiac muscle and valves before as well as after the stress of the heart and muscle. Report further covers segments of technology which includes 2D Ultrasound, 3D & 4D ultrasound and doppler imaging. The device display of cardiovascular ultrasound system market includescolordisplay and black & white display. Whereas the end users of cardiovascular ultrasound system market include hospital and cardiology centers, home and ambulatory care settings and others end users. The home and ambulatory care settings segment is expected to grow at fastest rate during the forecast period owing to growing the usage of echocardiographs at the patient's house.

Geographically, Europe is the largest market region for global cardiovascular ultrasound system market in terms of market revenue share in 2015. The key factors driving the market growth in Europe region is increasing cardiovascular disease. According to European heart network in Europe, each year cardiovascular disease causes around 3.9 million deaths in Europe. However, Asia Pacific is expected to emerge as the fastest growing market region during the forecast period 2016-2023 owing to increasing healthcare expenditure and medical tourism.

The major key players in this market such as Siemens Healthcare (Germany) Philips Healthcare( NetherLand), Toshiba Medical System Corporation (Japan), Mindray Medical International Limited (China) Hitachi Medical Corporation (Japan) and others. These players adopt various strategies including merger, partnership, new product development, collaboration, investment and expansion in the cardiovascular ultrasound system market.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

  • 2.1. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET: EVOLUTION & TRANSITION
  • 2.2. MARKET DEFINITION & SCOPE
  • 2.3. INDUSTRY STRUCTURE
  • 2.4. TOTAL MARKET ANALYSIS
    • 2.4.1. TOP 5 FINDINGS
    • 2.4.2. TOP 5 OPPORTUNITY MARKETS
    • 2.4.3. TOP 5 COMPANIES
    • 2.4.4. TOP 3 COMPETITIVE STRATEGIES
  • 2.5. ESTIMATION ANALYSIS
  • 2.6. STRATEGIC ANALYSIS
    • 2.6.1. INVESTMENT VS. ADOPTION MODEL
    • 2.6.2. 360-DEGREE INDUSTRY ANALYSIS
    • 2.6.3. PORTERS 5 FORCE MODEL
    • 2.6.4. SEE-SAW ANALYSIS
    • 2.6.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
  • 2.7. COMPETITIVE ANALYSIS
    • 2.7.1. KEY STRATEGIES & ANALYSIS
    • 2.7.2. MARKET SHARE ANALYSIS&TOP COMPANY ANALYSIS
  • 2.8. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
    • 2.8.1. INVESTMENT OPPORTUNITIES BY REGIONS
    • 2.8.2. OPPORTUNITIES IN EMERGING APPLICATIONS
    • 2.8.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. TECHNOLOGICAL ADVANCEMENT
    • 3.1.2. INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES
    • 3.1.3. ADVANTAGE OF ECHOCARDIOGRAPHY OVER INVASIVE CARDIAC DIAGNOSTIC PROCEDURES
    • 3.1.4. INCREASING HEALTHCARE EXPENDITURE
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. INSUFFICIENT REIMBURSEMENT SCENARIO
    • 3.2.2. ECONOMIC INFLUENCE OF ADOPTING NEW TECHNOLOGIES
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. UNTAPPED APAC REGION HAS HUGE SCOPE FOR ULTRASOUND SYSTEM
    • 3.3.2. MINIATURIZATION OF ULTRASOUND DEVICES
  • 3.4. MARKET CHALLENGES
    • 3.4.1. STRINGENT GOVERNMENT POLICIES AND REGULATIONS
    • 3.4.2. LACK OF SKILLED SONOGRAPHERS

4. MARKET SEGMENTATION

  • 4.1. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKETBY TEST TYPE
    • 4.1.1. MARKET DEFINITION AND SCOPE
    • 4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.1.4. OPPORTUNITY MATRIX
    • 4.1.5. MARKET SEGMENTATION
      • 4.1.5.1. GLOBAL TRANSTHORACIC ECHOCARDIOGRAM MARKET
        • 4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.1.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.1.4. KEY CONCLUSIONS
      • 4.1.5.2. GLOBAL TRANSESOPHAGEAL ECHOCARDIOGRAM MARKET
        • 4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.2.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.2.4. KEY CONCLUSIONS
      • 4.1.5.3. GLOBAL STRESS ECHOCARDIOGRAM MARKET
        • 4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.3.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.3.4. KEY CONCLUSIONS
      • 4.1.5.4. GLOBAL OTHER ECHOCARDIOGRAMS MARKET
        • 4.1.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.4.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.4.4. KEY CONCLUSIONS
  • 4.2. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKETBY TECHNOLOGY
    • 4.2.1. MARKET DEFINITION AND SCOPE
    • 4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.2.4. OPPORTUNITY MATRIX
    • 4.2.5. MARKET SEGMENTATION
      • 4.2.5.1. GLOBAL 2D MARKET
        • 4.2.5.1.1. APPLICATION
        • 4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.1.4. KEY PLAYERS & KEY PRODUCTS
        • 4.2.5.1.5. KEY CONCLUSIONS
      • 4.2.5.2. GLOBAL 3D & 4D MARKET
        • 4.2.5.2.1. APPLICATION
        • 4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.2.4. KEY PLAYERS & KEY PRODUCTS
        • 4.2.5.2.5. KEY CONCLUSIONS
      • 4.2.5.3. GLOBAL DOPPLER IMAGING MARKET
        • 4.2.5.3.1. APPLICATION
        • 4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.3.4. KEY PLAYERS & KEY PRODUCTS
        • 4.2.5.3.5. KEY CONCLUSIONS
  • 4.3. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKETBY DEVICE DISPLAY
    • 4.3.1. MARKET DEFINITION AND SCOPE
    • 4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.3.4. OPPORTUNITY MATRIX
    • 4.3.5. MARKET SEGMENTATION
      • 4.3.5.1. GLOBAL COLOR DISPLAYMARKET
        • 4.3.5.1.1. APPLICATION
        • 4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.1.4. KEY PLAYERS & KEY PRODUCTS
        • 4.3.5.1.5. KEY CONCLUSIONS
      • 4.3.5.2. GLOBAL BLACK & WHITE DISPLAY MARKET
        • 4.3.5.2.1. APPLICATION
        • 4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.2.4. KEY PLAYERS & KEY PRODUCTS
        • 4.3.5.2.5. KEY CONCLUSIONS
  • 4.4. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKETBY END USER
    • 4.4.1. MARKET DEFINITION AND SCOPE
    • 4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.4.4. OPPORTUNITY MATRIX
    • 4.4.5. MARKET SEGMENTATION
      • 4.4.5.1. GLOBAL HOSPITALS/CARDIOLOGY CENTERSMARKET
        • 4.4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.1.3. KEY PLAYERS & KEY PRODUCTS
        • 4.4.5.1.4. KEY CONCLUSIONS
      • 4.4.5.2. GLOBAL AMBULATORY/HOME CARE MARKET
        • 4.4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.2.3. KEY PLAYERS & KEY PRODUCTS
        • 4.4.5.2.4. KEY CONCLUSIONS
      • 4.4.5.3. GLOBAL OTHERS MARKET
        • 4.4.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.3.3. KEY PLAYERS & KEY PRODUCTS
        • 4.4.5.3.4. KEY CONCLUSIONS

5. COMPETITIVE LANDSCAPE

  • 5.1. KEY STRATEGIES
    • 5.1.1. LIST OF MERGER & ACQUISITION
    • 5.1.2. LIST OF JOINT VENTURE
    • 5.1.3. LIST OF PRODUCT LAUNCHES
    • 5.1.4. LIST OF PARTNERSHIP
  • 5.2. TOP 10 COMPANY ANALYSIS

6. GEOGRAPHY ANALYSIS

  • 6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
  • 6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
  • 6.3. OPPORTUNITY MATRIX
  • 6.4. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY REGION 2014-2023 ($ MILLION)
    • 6.4.1. NORTH AMERICA
      • 6.4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.1.2. TOP COUNTRY ANALYSIS
        • 6.4.1.2.1. U.S.
          • 6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.1.2.1.3. KEY CONCLUSIONS
        • 6.4.1.2.2. CANADA
          • 6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.1.2.2.3. KEY CONCLUSIONS
    • 6.4.2. EUROPE
      • 6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.2.2. TOP COUNTRY ANALYSIS
        • 6.4.2.2.1. UK
          • 6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.1.3. KEY CONCLUSIONS
        • 6.4.2.2.2. FRANCE
          • 6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.2.3. KEY CONCLUSIONS
        • 6.4.2.2.3. GERMANY
          • 6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.3.3. KEY CONCLUSIONS
        • 6.4.2.2.4. RUSSIA
          • 6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.4.3. KEY CONCLUSIONS
        • 6.4.2.2.5. REST OF EUROPE
          • 6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.5.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.5.3. KEY CONCLUSIONS
    • 6.4.3. ASIA PACIFIC
      • 6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.3.2. TOP COUNTRY ANALYSIS
        • 6.4.3.2.1. CHINA
          • 6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.1.3. KEY CONCLUSIONS
        • 6.4.3.2.2. INDIA
          • 6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.2.3. KEY CONCLUSIONS
        • 6.4.3.2.3. JAPAN
          • 6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.3.3. KEY CONCLUSIONS
        • 6.4.3.2.4. AUSTRALIA
          • 6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.4.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.4.3. KEY CONCLUSIONS
        • 6.4.3.2.5. REST OF ASIA PACIFIC
          • 6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.5.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.5.3. KEY CONCLUSIONS
    • 6.4.4. ROW
      • 6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.4.2. TOP COUNTRY ANALYSIS
        • 6.4.4.2.1. LATIN AMERICA
          • 6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.4.2.1.3. KEY CONCLUSIONS
        • 6.4.4.2.2. MIDDLE EAST & AFRICA
          • 6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.4.2.2.3. KEY CONCLUSIONS

7. COMPANY PROFILES

  • 7.1. GE HEALTHCARE (U.S.)
    • 7.1.1. OVERVIEW
    • 7.1.2. PRODUCT PORTFOLIO
    • 7.1.3. STRATEGIC INITIATIVES
    • 7.1.4. SCOT ANALYSIS
    • 7.1.5. STRATEGIC ANALYSIS
  • 7.2. PHILIPS HEALTHCARE (THE NETHERLANDS)
    • 7.2.1. OVERVIEW
    • 7.2.2. PRODUCT PORTFOLIO
    • 7.2.3. STRATEGIC INITIATIVES
    • 7.2.4. SCOT ANALYSIS
    • 7.2.5. STRATEGIC ANALYSIS
  • 7.3. SIEMENS HEALTHCARE (GERMANY)
    • 7.3.1. OVERVIEW
    • 7.3.2. PRODUCT PORTFOLIO
    • 7.3.3. STRATEGIC INITIATIVES
    • 7.3.4. SCOT ANALYSIS
    • 7.3.5. STRATEGIC ANALYSIS
  • 7.4. HITACHI MEDICAL CORPORATION (JAPAN)
    • 7.4.1. OVERVIEW
    • 7.4.2. PRODUCT PORTFOLIO
    • 7.4.3. STRATEGIC INITIATIVES
    • 7.4.4. SCOT ANALYSIS
    • 7.4.5. STRATEGIC ANALYSIS
  • 7.5. TOSHIBA MEDICAL SYSTEMS CORPORATION (JAPAN).
    • 7.5.1. OVERVIEW
    • 7.5.2. PRODUCT PORTFOLIO
    • 7.5.3. STRATEGIC INITIATIVES
    • 7.5.4. SCOT ANALYSIS
    • 7.5.5. STRATEGIC ANALYSIS
  • 7.6. MINDRAY MEDICAL INTERNATIONAL LIMITED ( CHINA)
    • 7.6.1. OVERVIEW
    • 7.6.2. PRODUCT PORTFOLIO
    • 7.6.3. STRATEGIC INITIATIVES
    • 7.6.4. SCOT ANALYSIS
    • 7.6.5. STRATEGIC ANALYSIS
  • 7.7. SAMSUNG ELECTRONICS CO., LTD. ( SOUTH KOREA)
    • 7.7.1. OVERVIEW
    • 7.7.2. PRODUCT PORTFOLIO
    • 7.7.3. STRATEGIC INITIATIVES
    • 7.7.4. SCOT ANALYSIS
    • 7.7.5. STRATEGIC ANALYSIS
  • 7.8. FUJIFILM HOLDINGS CORPORATION ( JAPAN)
    • 7.8.1. OVERVIEW
    • 7.8.2. PRODUCT PORTFOLIO
    • 7.8.3. STRATEGIC INITIATIVES
    • 7.8.4. SCOT ANALYSIS
    • 7.8.5. STRATEGIC ANALYSIS
  • 7.9. ESAOTE S.P.A. ( ITALY)
    • 7.9.1. OVERVIEW
    • 7.9.2. PRODUCT PORTFOLIO
    • 7.9.3. STRATEGIC INITIATIVES
    • 7.9.4. SCOT ANALYSIS
    • 7.9.5. STRATEGIC ANALYSIS
  • 7.10. CHISON MEDICAL IMAGING CO., LTD. (CHINA.)
    • 7.10.1. OVERVIEW
    • 7.10.2. PRODUCT PORTFOLIO
    • 7.10.3. STRATEGIC INITIATIVES
    • 7.10.4. SCOT ANALYSIS
    • 7.10.5. STRATEGIC ANALYSIS
  • 7.11. ULTRASOUND TECHNOLOGIES LTD.( UK)
    • 7.11.1. OVERVIEW
    • 7.11.2. PRODUCT PORTFOLIO
    • 7.11.3. STRATEGIC INITIATIVES
    • 7.11.4. SCOT ANALYSIS
    • 7.11.5. STRATEGIC ANALYSIS
  • 7.12. UNETIXS VASCULAR, INC. ( U.S)
    • 7.12.1. OVERVIEW
    • 7.12.2. PRODUCT PORTFOLIO
    • 7.12.3. STRATEGIC INITIATIVES
    • 7.12.4. SCOT ANALYSIS
    • 7.12.5. STRATEGIC ANALYSIS
  • 7.13. KALAMED MEDICAL SYSTEMS ( GERMANY)
    • 7.13.1. OVERVIEW
    • 7.13.2. PRODUCT PORTFOLIO
    • 7.13.3. STRATEGIC INITIATIVES
    • 7.13.4. SCOT ANALYSIS
    • 7.13.5. STRATEGIC ANALYSIS
  • 7.14. TRIVITRON HEALTHCARE ( INDIA)
    • 7.14.1. OVERVIEW
    • 7.14.2. PRODUCT PORTFOLIO
    • 7.14.3. STRATEGIC INITIATIVES
    • 7.14.4. SCOT ANALYSIS
    • 7.14.5. STRATEGIC ANALYSIS
  • 7.15. SUPERSONIC IMAGINE (FRANCE)
    • 7.15.1. OVERVIEW
    • 7.15.2. PRODUCT PORTFOLIO
    • 7.15.3. STRATEGIC INITIATIVES
    • 7.15.4. SCOT ANALYSIS
    • 7.15.5. STRATEGIC ANALYSIS

LIST OF TABLES

  • 1. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKETBY TEST TYPE 2014-2023 ($ MILLION)
  • 2. GLOBAL TRANSTHORACIC ECHOCARDIOGRAM MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 3. GLOBAL TRANSESOPHAGEAL ECHOCARDIOGRAM MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 4. GLOBAL STRESS ECHOCARDIOGRAM MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 5. GLOBAL OTHER ECHOCARDIOGRAMS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 6. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BYTECHNOLOGY2014-2023 ($ MILLION)
  • 7. GLOBAL 2D MARKETBY GEOGRAPHY 2014-2023 ($ MILLION)
  • 8. GLOBAL 3D & 4D MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 9. GLOBAL DOPPLER IMAGINGMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 10. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY DEVICE DISPLAY 2014-2023 ($ MILLION)
  • 11. GLOBAL COLORDISPLAY MARKETBY GEOGRAPHY2014-2023 ($ MILLION)
  • 12. GLOBAL BLACK & WHITE DISPLAY MARKET BY GEOGRAPHY2014-2023 ($ MILLION)
  • 13. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY END USER 2014-2023 ($ MILLION)
  • 14. GLOBAL HOSPITAL AND CARDIOLOGY CENTERS MARKET BY GEOGRAPHY2014-2023 ($ MILLION)
  • 15. GLOBAL HOME AND AMBULATORY CARE SETTINGS MARKET BY GEOGRAPHY2014-2023 ($ MILLION)
  • 16. GLOBALOTHER END USERS MARKET BY GEOGRAPHY2014-2023 ($ MILLION)
  • 17. NORTH AMERICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
  • 18. EUROPE CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
  • 19. ASIA PACIFIC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
  • 20. REST OF THE WORLD CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL TRANSTHORACIC ECHOCARDIOGRAM MARKET 2014-2023 ($ MILLION)
  • 2. GLOBAL TRANSESOPHAGEAL ECHOCARDIOGRAM MARKET 2014-2023 ($ MILLION)
  • 3. GLOBAL STRESS ECHOCARDIOGRAM MARKET 2014-2023 ($ MILLION)
  • 4. GLOBAL OTHER ECHOCARDIOGRAMS MARKET 2014-2023 ($ MILLION)
  • 5. GLOBAL 2D MARKET2014-2023 ($ MILLION)
  • 6. GLOBAL 3D & 4D MARKET 2014-2023 ($ MILLION)
  • 7. GLOBAL DOPPLER IMAGINGMARKET 2014-2023 ($ MILLION)
  • 8. GLOBAL COLORDISPLAY MARKET 2014-2023 ($ MILLION)
  • 9. GLOBAL BLACK & WHITE DISPLAY MARKET 2014-2023 ($ MILLION)
  • 10. GLOBAL HOSPITAL AND CARDIOLOGY CENTERS MARKET 2014-2023 ($ MILLION)
  • 11. GLOBAL HOME AND AMBULATORY CARE SETTINGS MARKET 2014-2023 ($ MILLION)
  • 12. GLOBALOTHER END USERS MARKET2014-2023 ($ MILLION)
  • 13. UNITED STATES (U.S.) CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
  • 14. CANADA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
  • 15. UNITED KINGDOM (UK) CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
  • 16. FRANCE CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
  • 17. GERMANY CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
  • 18. RUSSIA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
  • 19. ROE CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
  • 20. INDIA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
  • 21. CHINA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
  • 22. JAPAN CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
  • 23. AUSTRALIACARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
  • 24. ROAPAC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
  • 25. LATIN AMERICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
  • 26. MENA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
Back to Top